ClinicalTrials.Veeva

Menu

The Effect of Nasal Hair on Nasal Obstruction

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Nasal Obstruction

Treatments

Procedure: Vibrissae trimming
Drug: Application of oxymetazoline

Study type

Interventional

Funder types

Other

Identifiers

NCT01850511
12-001362

Details and patient eligibility

About

Nasal obstruction is a common complaint prompting presentation to an otolaryngologist. Many studies have been performed quantifying and describing the impact of a number of factors on symptoms of nasal obstruction, including anatomical, neoplastic, infectious, and inflammatory causes. Despite this scrutiny, no attention has been paid to the nasal vibrissae as a potential anatomical contributor to nasal obstruction. The proposed study intends to elucidate that contribution, if any exists.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Presence of nasal vibrissae
  • Able to tolerate rhinomanometry

Exclusion criteria

  • Anatomical or other obvious cause of obstruction
  • Claustrophobia with rhinomanometry mask

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Vibrissae trimming
Experimental group
Description:
Patients will serve as their own control, with assessment of primary outcomes pre- and post-trimming of vibrissae.
Treatment:
Drug: Application of oxymetazoline
Procedure: Vibrissae trimming

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems